Immunodiagnostic Systems Share Discussion Threads

[horneblower] 24/8/2007 09:21

I just put toe in water with 2,000 at 225p.

[nurdin] 24/8/2007 08:21

If Horneblower is right we should see a decent move today....signs are good :o)

[myoldmate] 23/8/2007 22:39

For what it's worth, JTCod a poster I greatly respect, pays homage to the charting skills of Mr horneblower so respect due. Good to see you here.

[nurdin] 23/8/2007 18:21

Buying creates a bullish chart...so both thoeries are correct :o)

[horneblower] 23/8/2007 18:14

Ah well.
Each to his own.
I like the chart a lot and will probably be buying some.

[silverfern] 23/8/2007 18:12

Just posted the same! No disrepect, really, but charts showing tram lines when a wider market is in turmoil and business-changing acquisitions are going on, are not the best measure, especially when buys signalled as sells on ADVFN is more likely the reason.

[nurdin] 23/8/2007 18:08

Thanks horneblower..I like the reason :o)

More realistically however, it appears that that 25k T trade might be from yesterday or a few days back which probably cleared some of the overhang.Seems there is lot of buying in the back ground, the trades for which should appear over the next few days...

Fundamentals are great too by the way....

[horneblower] 23/8/2007 17:56

Nurdin,
You may not like the reason but imo this is why, it's at the bottom of its growth channel.

[nurdin] 23/8/2007 17:34

Wonder why the share price went up this pm....certainly nothing in the trades which would explain it.Any theories anyone?

[nurdin] 19/8/2007 07:13

All correct Silver...and no ones going to tell you off...:o)

With the talk of global recession and the current vicious market conditions,IDH also offer defensive qualities which I am sure will not have escaped the attention of many investors.I feel happy holding here and may even add if the price comes off more.

[silverfern] 18/8/2007 22:55

I'm going to be told off for getting this half right, but a) IDH expects to grow their business double digit anyway, and b) the purchase of Nordic was cheap and will be earnings enhancing anyway and c) business for the 3x3 test gear will be assured on the basis of a) and b) in Euopre and likely worldwide by '09. So going forward the eps for 08 will be double digit growth for a) and b) diluted by the wait for c) but could still be +10-15% overall so the current price is good value given that institutions bought into the arguement at 251p for Nordic and 240p for 3x3. And for '09 (which share prices will reflect by Feb '08) this could be maga and 205p will look very cheap. Also, the company has not put a foot wrong in three years and seems to have recruited some strategic and persausive managers.

Oh, as to some other companies 'sniffing' around Biocode - good, who wants to buy a company no-one else wants to own?

[myoldmate] 15/8/2007 18:29

That was a first for me.

[nurdin] 15/8/2007 17:16

I should read the RNSes ;o)

[myoldmate] 15/8/2007 17:11

From the RNS.

'The instrument will initially be offered for sale first in the EU, with launches in other major territories, such as the USA and Japan, delayed for approximately 12 months by regulatory requirements. The 3X3 Instrument will be sold through existing and new Alliance members, with the ability of partners to offer products of other Alliance members in many territories, broadening geographic reach.'

[nurdin] 15/8/2007 17:05

cheers myoldmate...was not aware of the rumour.

One year for US approval seems long for test equipment...but you could be right

[nurdin] 15/8/2007 16:07

Although they appear to have overpaid for Biocode Hycel (BH),a closer scrunity shows that this is a brilliant buy and could be significantly earnings enhancing going forward.Heres why:

-BH adds a diversified portfolio of products to the IDS market
-BH have had no proper sales channels beyond France.IDH plan lift the market exposure of BH products in rest of Europe and the USA through their own sales channels
-the crucial element however is the ownership of the properiety 3x3 automation equipmentThis will allow IDH to automate their own instruments as well as those of the Nordic company acquired rcently.
-automated equipment is in great demand in large establishments where they perform thousands of tests per day.In other words the acquisition opens the door to a much bigger market hitherto not addressed by IDH
-with much higher throughput facilated by automated equipment,there is likely to be significant uplift in the sales of reagents(consumables) which are much higher margins than the equipment itself
-improved margins should fall straight to the bottom line as the CEO has already hinted
-so,although they appear to have overpaid for what has been a loss making company,the acquisition gives them significant leverage in what is undoubtedly a fast growing market

Brokers note due out on 29 Aug should provide some meat on the bones to my rambling :o)

[diogenesj] 15/8/2007 15:24

Thanks, nurdin. Looks as though there may be a lot of disgruntled institutions out there.

[nurdin] 15/8/2007 07:11

Diogenes...yes,having spoken to the company I can confirm that the placing at 240p has been fully subscribed and the shares will be placed immediately after the egm.

[diogenesj] 14/8/2007 21:19

Are you sure of that, Felix? What I saw was that they were raising a lot of money and issuing a lot of dilutive shares to buy a loss-making company. But I admit I did not do any serious calculations (there wasn't enough information anyway). I was also slightly put off by the rather OTT language of the announcement.

[felix99] 14/8/2007 16:53

the placing is sorted I understand - they wouldnt do it not underwritten if there were any worries about placing the stock

Diogenes - yes we know Inst are idiots but at a near 20% discount to the placing that leaves enough margin for error in my book.

Its all straight profit to bottom line the acquisition - its actually a pretty sweet deal if you research it

[v01101999] 14/8/2007 13:45

do we know if the institutions have subscribed for the latest placing. I have not seen an announcement to that effect and also the RNS mentioned that the placing is *NOT* underwritten.

[diogenesj] 14/8/2007 12:37

On the other hand, F, if we all based our investments on the theory that institutions know what they are doing, most of us would be much poorer.

[felix99] 14/8/2007 12:30

Thanks Sheena - just one of those silly buying oppos that no one has the balls to go for . Ah well. Patience for us holders.

Don;t think Inst would have subscribed at 240p if they didnt think that was dirt cheap at the time. And I know share price was nearer £3 but the Inst dont care and they will look at it all and just say its worth £2 for a placing or whatever. They came up with 240p and nothing has changed bar the markets and some daft sellers.